Radiolabeling Techniques in Diagnostic Imaging

Radiolabeling techniques underpin a wide range of modern diagnostic imaging modalities by attaching radionuclides to biologically active molecules. The choice of isotope—commonly fluorine-18, gallium-68 or technetium-99m for positron emission tomography (PET) and single-photon emission computed tomography (SPECT) respectively—depends on physical half-life, decay mode and photon energy. Two principal strategies prevail: direct labelling, in which the radionuclide is incorporated into the target molecule via electrophilic or nucleophilic substitution; and indirect labelling, which uses bifunctional chelators to coordinate metallic radionuclides without perturbing biological activity. Critical parameters include radiochemical yield, in vitro and in vivo stability, pharmacokinetics and target-to-background contrast. Recent advances have focused on click chemistry for rapid and high-yield conjugation, microfluidic platforms for automated synthesis and kit-based approaches that simplify translation to clinical practice. Innovations in peptide and antibody labelling have enabled the development of theranostic pairs, combining diagnostic imaging and radionuclide therapy. Nanoparticle and liposome vectors bearing multiple chelators permit multivalent targeting and improved signal amplification. Contemporary research also emphasises optimisation of reaction pH, ligand excess and reaction time to maximise labelling efficiency and minimise free radionuclide. Taken together, these developments have widened the scope of molecular imaging, allowing precise visualisation of cardiac perfusion, tumour metabolism, neuroreceptor distribution and inflammatory processes on a global scale.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Radiolabeling Techniques in Diagnostic Imaging publication trend

The graph below shows the total number of articles in radiolabeling techniques in diagnostic imaging across all publications each year (not limited to Nature Index journals).

Technical terms

Radiolabelling: The process of incorporating a radioactive isotope into a molecule to track its distribution in biological systems.

Radiochemical yield: The proportion of total radioactivity that becomes bound to the target molecule under specific reaction conditions.

Bifunctional chelator: A molecule that binds both a radionuclide and a biomolecule, enabling indirect labelling of proteins or peptides.

Positron emission tomography (PET): An imaging modality that detects pairs of gamma photons produced by positron-emitting radionuclides to map physiological processes.

Single-photon emission computed tomography (SPECT): An imaging modality that records gamma rays emitted directly by radionuclides to visualise functional information in three dimensions.

References

1. Synthesis and biological evaluation of [131I]iodocarvedilol as a potential radiopharmaceutical for heart imaging. BMC Chemistry (2023).
2. Synthesis, 99mTc-labeling, in-vivo study and in-silico investigation of 6-amino-5-[(bis-(2-hydroxy-ethyl)-amino]methyl]2-methyl pyrimidin-4-ol as a potential probe for tumor targeting. Journal of Radioanalytical and Nuclear Chemistry (2022).
3. Radiolabeling and evaluation of fonturacetam hydrazide as a radiotracer for visualization of brain function. Journal of Radioanalytical and Nuclear Chemistry (2023).